Mohammed Mohammed, MD
Pulmonary Disease · Grafton, WINPI 1922246164
Payments from drug & device makers
What this record shows
This record is dominated by education: $6,000 of the $9,312 with a category attached, or 64.4%. Intuitive Surgical accounts for 89.5% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2022 at $8,243 and has fallen 92.9% since, to $583 in 2025.
Across 46 payments — averaging $202.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$8K
- AbbVie$600
- Pulmonx Corporation$140
- Regeneron Healthcare Solutions, Inc.$138
- Mylan Specialty L.p.$100
What the payments were for
- Travel & lodging$1,90820%
- Food & beverage$1,40415%
- Education$6,00064%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 16 | $8,334 |
| AbbVie(2 entities) | 27 | $600 |
| Pulmonx Corporation | 1 | $140 |
| Regeneron Healthcare Solutions, Inc. | 1 | $138 |
| Mylan Specialty L.p. | 1 | $100 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ION$3,000
- DAVINCI XI$3,000
- Da Vinci Surgical System$1,987
- CHARTIS CATHETER$140
- ZEPHYR DELIVERY CATHETER$140
- ZEPHYR ENDOBRONCHIAL VALVE$140
- PULMONX CHARTIS TABLET CONSOLE$140
- LIBTAYO$138
- EMBLAVEO$125
- Yupelri$100
How this compares
$9,312 in reported general payments places this provider in the 85th percentile of 247 pulmonary disease providers in Wisconsin.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 367 | $310,697 |
| Breo ElliptaFluticasone/Vilanterol | 154 | $89,283 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 142 | $81,194 |
| Spiriva RespimatTiotropium Bromide | 73 | $62,418 |
| Spiriva HandihalerTiotropium Bromide | 51 | $39,149 |
| Incruse ElliptaUmeclidinium Bromide | 69 | $30,204 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 183 | $19,689 |
| SymbicortBudesonide/Formoterol Fumarate | 61 | $19,379 |
| Advair HfaFluticasone Propion/Salmeterol | 30 | $15,738 |
| Wixela InhubFluticasone Propion/Salmeterol | 75 | $12,118 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 362 | $10,780 |
| Arnuity ElliptaFluticasone Furoate | 27 | $9,333 |
| Varenicline Tartrate | 33 | $5,491 |
| Roflumilast | 68 | $4,212 |
| Ventolin HfaAlbuterol Sulfate | 39 | $3,087 |
Paid to pharmacies, not to this prescriber.
Other pulmonary disease in Grafton
- Jonathan KurmanMilwaukee$803K
- Mouhammed RihawiMilwaukee$713K
- Hasnain BawaadamKenosha$686K
- Alfred HabelKenosha$194K
- Manar Al ShahrouriGreen Bay$61K
- Kurt HuMilwaukee$55K
- Julie BillerMilwaukee$52K
- Mark BarashMilwaukee$52K
- Rahul NanchalMilwaukee$42K
- Steven LehMilwaukee$40K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.